These phase 2 results have been peer reviewed, unlike the

Pfizer and the other one. I imagine Oxford have had these phase 2 results for quite a while, but have only published after peer review.

They've probably pretty much completed phase 3, awaiting peer review to release results. The others rushed out a press release in advance of that.

Interesting that the CEO of Pfizer scheduled the sale of £5.6m of shares for the day of their press release...

Oxford/AstraZeneca is non profit, so no need for the slightly dodgy rush.

Posted By: jamesward on November 19th 2020 at 10:05:25


Message Thread


Reply to Message

In order to add a post to the WotB Message Board you must be a registered WotB user.

If you are not yet registered then please visit the registration page. You should ensure that their browser is setup to accept cookies.

Log in